Cargando…
The survival rate of hepatocellular carcinoma in Asian countries: a systematic review and meta-analysis
Hepatocellular carcinoma or Liver cancer (LC) is the sixth most common cancer and the fourth cause of death worldwide in 2018. There has not been a comprehensive study on the survival rate of patients with LC in Asia yet. Therefore, the present study was conducted to evaluate the survival rate of pa...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Leibniz Research Centre for Working Environment and Human Factors
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003639/ https://www.ncbi.nlm.nih.gov/pubmed/32038120 http://dx.doi.org/10.17179/excli2019-1842 |
_version_ | 1783494571342168064 |
---|---|
author | Hassanipour, Soheil Vali, Mouhebat Gaffari-fam, Saber Nikbakht, Hossein-Ali Abdzadeh, Elham Joukar, Farahnaz Pourshams, Akram Shafaghi, Afshin Malakoutikhah, Mahdi Arab-Zozani, Morteza Salehiniya, Hamid Mansour-Ghanaei, Fariborz |
author_facet | Hassanipour, Soheil Vali, Mouhebat Gaffari-fam, Saber Nikbakht, Hossein-Ali Abdzadeh, Elham Joukar, Farahnaz Pourshams, Akram Shafaghi, Afshin Malakoutikhah, Mahdi Arab-Zozani, Morteza Salehiniya, Hamid Mansour-Ghanaei, Fariborz |
author_sort | Hassanipour, Soheil |
collection | PubMed |
description | Hepatocellular carcinoma or Liver cancer (LC) is the sixth most common cancer and the fourth cause of death worldwide in 2018. There has not been a comprehensive study on the survival rate of patients with LC in Asia yet. Therefore, the present study was conducted to evaluate the survival rate of patients with LC in Asian countries. The methodology of the present study is based on the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analysis) statement. The researchers searched five international databases including Medline/PubMed, Scopus, Embase, Web of Knowledge and ProQuest until July 1, 2018. We also searched Google Scholar for detecting grey literature. The Newcastle-Ottawa Quality Assessment Form was used to evaluate the quality of selected papers. A total of 1425 titles were retrieved. 63 studies met the inclusion criteria. Based on the random-effect model one-year, three-year and five-year survival rate of LC were 34.8 % (95 % CI; 30.3-39.3), 19 % (95 % CI ; 18.2-21.8) and 18.1 % (95 % CI ;16.1-20.1) respectively. According to the results of our study, the LC survival rate in Asian countries is relatively lower than in Europe and North America. |
format | Online Article Text |
id | pubmed-7003639 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Leibniz Research Centre for Working Environment and Human Factors |
record_format | MEDLINE/PubMed |
spelling | pubmed-70036392020-02-09 The survival rate of hepatocellular carcinoma in Asian countries: a systematic review and meta-analysis Hassanipour, Soheil Vali, Mouhebat Gaffari-fam, Saber Nikbakht, Hossein-Ali Abdzadeh, Elham Joukar, Farahnaz Pourshams, Akram Shafaghi, Afshin Malakoutikhah, Mahdi Arab-Zozani, Morteza Salehiniya, Hamid Mansour-Ghanaei, Fariborz EXCLI J Review Article Hepatocellular carcinoma or Liver cancer (LC) is the sixth most common cancer and the fourth cause of death worldwide in 2018. There has not been a comprehensive study on the survival rate of patients with LC in Asia yet. Therefore, the present study was conducted to evaluate the survival rate of patients with LC in Asian countries. The methodology of the present study is based on the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analysis) statement. The researchers searched five international databases including Medline/PubMed, Scopus, Embase, Web of Knowledge and ProQuest until July 1, 2018. We also searched Google Scholar for detecting grey literature. The Newcastle-Ottawa Quality Assessment Form was used to evaluate the quality of selected papers. A total of 1425 titles were retrieved. 63 studies met the inclusion criteria. Based on the random-effect model one-year, three-year and five-year survival rate of LC were 34.8 % (95 % CI; 30.3-39.3), 19 % (95 % CI ; 18.2-21.8) and 18.1 % (95 % CI ;16.1-20.1) respectively. According to the results of our study, the LC survival rate in Asian countries is relatively lower than in Europe and North America. Leibniz Research Centre for Working Environment and Human Factors 2020-01-13 /pmc/articles/PMC7003639/ /pubmed/32038120 http://dx.doi.org/10.17179/excli2019-1842 Text en Copyright © 2020 Hassanipour et al. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Licence (http://creativecommons.org/licenses/by/4.0/) You are free to copy, distribute and transmit the work, provided the original author and source are credited. |
spellingShingle | Review Article Hassanipour, Soheil Vali, Mouhebat Gaffari-fam, Saber Nikbakht, Hossein-Ali Abdzadeh, Elham Joukar, Farahnaz Pourshams, Akram Shafaghi, Afshin Malakoutikhah, Mahdi Arab-Zozani, Morteza Salehiniya, Hamid Mansour-Ghanaei, Fariborz The survival rate of hepatocellular carcinoma in Asian countries: a systematic review and meta-analysis |
title | The survival rate of hepatocellular carcinoma in Asian countries: a systematic review and meta-analysis |
title_full | The survival rate of hepatocellular carcinoma in Asian countries: a systematic review and meta-analysis |
title_fullStr | The survival rate of hepatocellular carcinoma in Asian countries: a systematic review and meta-analysis |
title_full_unstemmed | The survival rate of hepatocellular carcinoma in Asian countries: a systematic review and meta-analysis |
title_short | The survival rate of hepatocellular carcinoma in Asian countries: a systematic review and meta-analysis |
title_sort | survival rate of hepatocellular carcinoma in asian countries: a systematic review and meta-analysis |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003639/ https://www.ncbi.nlm.nih.gov/pubmed/32038120 http://dx.doi.org/10.17179/excli2019-1842 |
work_keys_str_mv | AT hassanipoursoheil thesurvivalrateofhepatocellularcarcinomainasiancountriesasystematicreviewandmetaanalysis AT valimouhebat thesurvivalrateofhepatocellularcarcinomainasiancountriesasystematicreviewandmetaanalysis AT gaffarifamsaber thesurvivalrateofhepatocellularcarcinomainasiancountriesasystematicreviewandmetaanalysis AT nikbakhthosseinali thesurvivalrateofhepatocellularcarcinomainasiancountriesasystematicreviewandmetaanalysis AT abdzadehelham thesurvivalrateofhepatocellularcarcinomainasiancountriesasystematicreviewandmetaanalysis AT joukarfarahnaz thesurvivalrateofhepatocellularcarcinomainasiancountriesasystematicreviewandmetaanalysis AT pourshamsakram thesurvivalrateofhepatocellularcarcinomainasiancountriesasystematicreviewandmetaanalysis AT shafaghiafshin thesurvivalrateofhepatocellularcarcinomainasiancountriesasystematicreviewandmetaanalysis AT malakoutikhahmahdi thesurvivalrateofhepatocellularcarcinomainasiancountriesasystematicreviewandmetaanalysis AT arabzozanimorteza thesurvivalrateofhepatocellularcarcinomainasiancountriesasystematicreviewandmetaanalysis AT salehiniyahamid thesurvivalrateofhepatocellularcarcinomainasiancountriesasystematicreviewandmetaanalysis AT mansourghanaeifariborz thesurvivalrateofhepatocellularcarcinomainasiancountriesasystematicreviewandmetaanalysis AT hassanipoursoheil survivalrateofhepatocellularcarcinomainasiancountriesasystematicreviewandmetaanalysis AT valimouhebat survivalrateofhepatocellularcarcinomainasiancountriesasystematicreviewandmetaanalysis AT gaffarifamsaber survivalrateofhepatocellularcarcinomainasiancountriesasystematicreviewandmetaanalysis AT nikbakhthosseinali survivalrateofhepatocellularcarcinomainasiancountriesasystematicreviewandmetaanalysis AT abdzadehelham survivalrateofhepatocellularcarcinomainasiancountriesasystematicreviewandmetaanalysis AT joukarfarahnaz survivalrateofhepatocellularcarcinomainasiancountriesasystematicreviewandmetaanalysis AT pourshamsakram survivalrateofhepatocellularcarcinomainasiancountriesasystematicreviewandmetaanalysis AT shafaghiafshin survivalrateofhepatocellularcarcinomainasiancountriesasystematicreviewandmetaanalysis AT malakoutikhahmahdi survivalrateofhepatocellularcarcinomainasiancountriesasystematicreviewandmetaanalysis AT arabzozanimorteza survivalrateofhepatocellularcarcinomainasiancountriesasystematicreviewandmetaanalysis AT salehiniyahamid survivalrateofhepatocellularcarcinomainasiancountriesasystematicreviewandmetaanalysis AT mansourghanaeifariborz survivalrateofhepatocellularcarcinomainasiancountriesasystematicreviewandmetaanalysis |